Imaging Dementia Evidence for Amyloid Scanning (IDEAS) Study

Mild Cognitive Impairment (MCI)

Principal Investigator: James Mastrianni, MD, PhD
Co-Principal Investigator: Daniel Applebaum, MD
Clinical Trials Coordinator: Breanna Bertacchi, BA

Status: Soon to be open for enrollment

The purpose of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study is to examine how brain imaging helps guide your doctor in how to treat your mild cognitive impairment, and whether these changes in your treatment plan lead to better health outcomes.

A one-time brain imaging, called the amyloid PET (positron emission tomography) scan, will be requested by your doctor as part of your standard of care.

The amyloid PET brain imaging will look at the build-up of amyloid plaques in the brain which has been linked with Alzheimer’s disease and other related diseases. The brain imaging is not being performed as part of the research; the actual part of the research study is to examine whether the imaging guides your medical treatment and improves health outcomes.

Medicare will pay for your amyloid PET imaging exam as a covered benefit.

The IDEAS Study plans on enrolling 18,000 participants worldwide and approximately 17 participants will take part in this study at the University of Chicago Memory Center for Comprehensive Care and Research on Memory Disorders. The IDEAS Study is directed by the Alzheimer’s Association in collaboration with the American College of Radiology, and the American College of Radiology Imaging Network (ACRIN).

To join this study you must:

  • Be 65 years or older

  • Be a Medicare beneficiary

  • Have a diagnosis of mild cognitive impairment (MCI) or dementia (will be determined by The Memory Center) and have Alzheimer’s disease as a diagnostic consideration

  • Meet additional study criteria

The principal investigator, James Mastrianni, MD, PhD, and our clinical trials coordinator, Breanna Bertacchi, will explain any potential risks and benefits to you and will describe the study procedures before you decide to join the study.

To learn more about this study, please contact:
Breanna Bertacchi at 773-834-1688